UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Korea among Big 4 in Asia Pacific’s hearing aid market’
by Lee Hye-seon
2018-01-18 15:42
Hepatitis C drug Mavyret arrives in Korea
by Lee Hye-seon
2018-01-15 11:19
Government bans dihydrocodeine for children under 12
by Lee Hye-seon
2018-01-12 14:35
Drugmakers work on ‘me-too’ drugs of Pradaxa
by Lee Hye-seon
2018-01-11 16:12
New antihypertensive combos ready for market entry
by Lee Hye-seon
2018-01-09 15:17
라인
Janssen to test RSV drug for Korean infants
by Lee Hye-seon
2018-01-08 14:29
Will Brilinta-Aspirin combo prevent stroke and death?
by Lee Hye-seon
2018-01-04 11:48
Will home-made AI medical devices come to market this year?
by Lee Hye-seon
2018-01-03 12:56
AstraZeneca to test asthma treatment in Korea
by Lee Hye-seon
2017-12-20 13:11
New migraine drugs prepare to hit domestic market
by Lee Hye-seon
2017-12-19 15:26
라인
Kwangdong punished for illegal ad of obesity drug
by Lee Hye-seon
2017-12-18 14:50
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
by Lee Hye-seon
2017-12-14 15:01
AstraZeneca to test Imfinzi on lung cancer patients
by Lee Hye-seon
2017-12-13 14:20
Korea approves Olumiant pills for treatment of rheumatoid arthritis
by Lee Hye-seon
2017-12-12 11:50
Government cancels approval for antidepressant Valdoxan
by Lee Hye-seon
2017-12-05 11:09
라인
What are doctors’ views on Invossa used even by foreign patients?
by Lee Hye-seon
2017-11-29 09:31
Pneumonia added to adverse reactions of hepatitis B drug Viread
by Lee Hye-seon
2017-11-28 16:07
Otezla, oral treatment for psoriasis, lands in Korea
by Lee Hye-seon
2017-11-24 11:53
‘Watson for Oncology, not medical device’
by Lee Hye-seon
2017-11-23 14:38
New drug re-evaluation requires global sales, approval reports
by Lee Hye-seon
2017-11-22 11:07
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top